William Blair Investment Management LLC raised its stake in Maximus, Inc. (NYSE:MMS - Free Report) by 22.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 518,469 shares of the health services provider's stock after purchasing an additional 94,067 shares during the quarter. William Blair Investment Management LLC owned 0.91% of Maximus worth $38,704,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors also recently modified their holdings of MMS. UMB Bank n.a. raised its position in Maximus by 79.8% in the 4th quarter. UMB Bank n.a. now owns 356 shares of the health services provider's stock valued at $27,000 after buying an additional 158 shares during the last quarter. Eastern Bank purchased a new stake in shares of Maximus in the fourth quarter valued at about $29,000. V Square Quantitative Management LLC lifted its position in shares of Maximus by 65.9% during the fourth quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock valued at $34,000 after purchasing an additional 180 shares in the last quarter. R Squared Ltd bought a new position in shares of Maximus during the fourth quarter valued at about $54,000. Finally, IFP Advisors Inc boosted its holdings in Maximus by 62.4% during the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock worth $59,000 after purchasing an additional 302 shares during the last quarter. Institutional investors own 97.21% of the company's stock.
Analyst Ratings Changes
Several equities research analysts have commented on MMS shares. Raymond James upgraded shares of Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price objective for the company in a research note on Thursday, January 2nd. StockNews.com downgraded Maximus from a "buy" rating to a "hold" rating in a research report on Friday, February 14th.
Read Our Latest Stock Analysis on MMS
Maximus Stock Performance
Shares of MMS traded down $0.09 during mid-day trading on Friday, hitting $67.12. The stock had a trading volume of 1,944,363 shares, compared to its average volume of 720,335. Maximus, Inc. has a 52 week low of $63.77 and a 52 week high of $93.97. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72. The business has a fifty day moving average price of $71.27 and a 200-day moving average price of $78.81. The firm has a market cap of $3.80 billion, a P/E ratio of 14.43 and a beta of 0.71.
Maximus (NYSE:MMS - Get Free Report) last issued its earnings results on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. On average, equities research analysts expect that Maximus, Inc. will post 6.15 EPS for the current year.
Maximus Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, February 28th. Stockholders of record on Saturday, February 15th were issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.79%. The ex-dividend date was Friday, February 14th. Maximus's dividend payout ratio is currently 25.81%.
Insider Buying and Selling
In related news, insider Ilene R. Baylinson sold 14,500 shares of the stock in a transaction on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total transaction of $988,030.00. Following the transaction, the insider now owns 2,512 shares of the company's stock, valued at approximately $171,167.68. This trade represents a 85.23 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Jan Madsen sold 2,439 shares of the business's stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total transaction of $165,144.69. Following the completion of the sale, the director now directly owns 18,097 shares of the company's stock, valued at $1,225,347.87. This represents a 11.88 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is owned by company insiders.
About Maximus
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
See Also

Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.